Lucid Inc. changes name to Caliber Imaging & Diagnostics

Rochester, N.Y. - Lucid Inc. is operating under a new company name - Caliber Imaging & Diagnostics Inc., or Caliber ID. The new name reflects the company's commitment to innovating and delivering the highest-caliber identification tools for accurate, rapid diagnosis to assist in the fight against skin cancer and other diseases, according to company reports.

Caliber ID’s reflectance confocal microscopy (RCM) technology allows physicians to detect and diagnose skin disease, including basal cell carcinoma, melanoma, and inflammatory and pigmentary disorders.

"This technology is clearly a clinically relevant diagnostic tool," says Martin C. Mihm Jr., M.D., associate physician at Brigham and Women's Hospital, Boston, clinical professor of pathology (dermatology) at Harvard Medical School and chairman of the Caliber ID scientific advisory board. "The clinical data indicates that this suite of technologies can substantially reduce the need to biopsy healthy tissue by giving physicians the ability to noninvasively image and diagnose skin cancers and other skin disease. In the hands of an experienced confocal user, resolution and accuracy is comparable to that of traditional histology."

The company has developed an integrated platform of tools, including the Caliber ID VivaScope 1500 and VivaScope 3000 imagers, along with a telepathology service that can be used by doctors, surgeons and research laboratories. Its tools are in use by doctors and researchers in major academic hospitals including Memorial Sloan-Kettering Cancer Center, New York, Brigham and Women's Hospital, the Charite Hospital, Berlin and the Melanoma Institute Australia, Sydney, Caliber ID reports.